Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALI SALIM SOUEIDAN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1053517540
CMS profile
138124
Location
BAY CITY, MI

General Payments · PY2018–2024

$7,810.58

  • Reported across 464 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$811.01

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $714.83 34
Education $96.18 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $982.78 77
PY2019 $1,472.60 94
PY2020 $1,390.68 81
PY2021 $1,461.99 89
PY2022 $1,324.87 73
PY2023 $366.65 14
PY2024 $811.01 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $15.08 03/05/2024 Food and Beverage Undisputed 01/23/2026 1104357241 CMS
AstraZeneca Pharmaceuticals LP $15.21 06/05/2024 Food and Beverage Undisputed 01/23/2026 1105443107 CMS
AstraZeneca Pharmaceuticals LP $16.25 07/05/2024 Food and Beverage Undisputed 01/23/2026 1105790158 CMS
AstraZeneca Pharmaceuticals LP $15.02 09/12/2024 Food and Beverage Undisputed 01/23/2026 1104248601 CMS
AstraZeneca Pharmaceuticals LP $16.39 11/20/2024 Food and Beverage Undisputed 01/23/2026 1105700674 CMS
AstraZeneca Pharmaceuticals LP $17.13 12/04/2024 Food and Beverage Undisputed 01/23/2026 1104275609 CMS
Baxter Healthcare $40.87 03/14/2024 Food and Beverage Undisputed 01/23/2026 1120633540 CMS
Baxter Healthcare $37.61 08/15/2024 Food and Beverage Undisputed 01/23/2026 1120633544 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.36 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086266243 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.71 11/07/2024 Food and Beverage Undisputed 01/23/2026 1086108302 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.00 12/16/2024 Food and Beverage Undisputed 01/23/2026 1117854197 CMS
Edwards Lifesciences Corporation $25.50 02/02/2024 Food and Beverage Undisputed 01/23/2026 1138800032 CMS
GENZYME CORPORATION $18.02 01/17/2024 Food and Beverage Undisputed 01/23/2026 1139812857 CMS
GENZYME CORPORATION $16.17 05/08/2024 Food and Beverage Undisputed 01/23/2026 1139812889 CMS
GENZYME CORPORATION $24.68 08/14/2024 Food and Beverage Undisputed 01/23/2026 1139812973 CMS
Gilead Sciences, Inc. $14.56 02/22/2024 Food and Beverage Undisputed 01/23/2026 1133827149 CMS
Gilead Sciences, Inc. $14.43 08/19/2024 Food and Beverage Undisputed 01/23/2026 1133827151 CMS
Gilead Sciences, Inc. $13.23 11/11/2024 Food and Beverage Undisputed 01/23/2026 1133827153 CMS
GlaxoSmithKline, LLC. $18.80 05/02/2024 Food and Beverage Undisputed 01/23/2026 1116685633 CMS
GlaxoSmithKline, LLC. $16.30 11/27/2024 Food and Beverage Undisputed 01/23/2026 1116386382 CMS
Grifols USA, LLC $22.95 08/27/2024 Food and Beverage Undisputed 01/23/2026 1124737637 CMS
Grifols USA, LLC $23.52 11/21/2024 Food and Beverage Undisputed 01/23/2026 1124737639 CMS
Insmed, Inc. $16.24 10/31/2024 Education Undisputed 01/23/2026 1089565367 CMS
Inspire Medical Systems, Inc. $14.77 02/19/2024 Food and Beverage Undisputed 01/23/2026 1148113881 CMS
Inspire Medical Systems, Inc. $15.58 04/04/2024 Food and Beverage Undisputed 01/23/2026 1148113885 CMS
Mallinckrodt Hospital Products Inc. $19.89 05/01/2024 Food and Beverage Undisputed 01/23/2026 1145140840 CMS
Mylan Specialty L.P. $24.27 03/09/2024 Food and Beverage Undisputed 01/23/2026 1147329246 CMS
Mylan Specialty L.P. $27.25 04/10/2024 Food and Beverage Undisputed 01/23/2026 1147373580 CMS
Mylan Specialty L.P. $25.45 04/24/2024 Food and Beverage Undisputed 01/23/2026 1147373635 CMS
Philips North America LLC $19.05 12/04/2024 Food and Beverage Undisputed 01/23/2026 1146876514 CMS
Regeneron Healthcare Solutions, Inc. $16.72 06/18/2024 Food and Beverage Undisputed 01/23/2026 1114187712 CMS
Regeneron Healthcare Solutions, Inc. $29.23 07/12/2024 Food and Beverage Undisputed 01/23/2026 1114187719 CMS
Regeneron Healthcare Solutions, Inc. $27.18 09/23/2024 Food and Beverage Undisputed 01/23/2026 1114187725 CMS
Regeneron Healthcare Solutions, Inc. $79.94 10/30/2024 Education Undisputed 01/23/2026 1114187731 CMS
Regeneron Healthcare Solutions, Inc. $32.30 11/04/2024 Food and Beverage Undisputed 01/23/2026 1114187739 CMS
ZOLL Respicardia, Inc. $17.35 06/10/2024 Food and Beverage Undisputed 01/23/2026 1146937110 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.